<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04885556</url>
  </required_header>
  <id_info>
    <org_study_id>AC-004</org_study_id>
    <nct_id>NCT04885556</nct_id>
  </id_info>
  <brief_title>Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort</brief_title>
  <official_title>Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atlantic Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Atlantic Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previous research has shown that semen deposition in the vagina after intercourse leads to&#xD;
      dripping, discomfort, and vaginal odor. This study is evaluating a hygiene device designed to&#xD;
      be inserted into the vagina after intercourse to absorb semen deposited into the vaginal&#xD;
      canal to determine if there is a reduction in dripping and odor, and to determine the amount&#xD;
      of fluids absorbed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite the significant number of sexual dysfunctions in women, physicians often avoid&#xD;
      discussing these concerns in the office setting. With recent research on the role of the&#xD;
      pelvic floor, and recently approved medical therapies for hypoactive sexual desire disorder,&#xD;
      physicians have begun to adapt to questioning patients about libido and pain-related sexual&#xD;
      dysfunctions. However, pain-related sexual questionnaires often focus on insertional and&#xD;
      penetrational dyspareunia, without asking about discomfort minutes, hours, or even the day&#xD;
      following sexual intercourse. One common compliant in ambulatory sexual medicine clinics is&#xD;
      the bothersome dripping, odor, and discomfort women experience after sexual activity when no&#xD;
      condom is used, and when intravaginal ejaculation occurs.&#xD;
&#xD;
      Previous studies have shown the effects of semen on alterations in the vaginal flora. These&#xD;
      changes contribute to a multitude of clinical complaints and diagnoses, including malodor,&#xD;
      continuous discharge after intercourse, and bacterial vaginosis (BV). The exposure of semen&#xD;
      changes the vaginal flora by increasing the pH levels, in turn altering the bacterial growth&#xD;
      pattern. This implies the persistent presence of semen in the vagina may be one of the causes&#xD;
      of malodor and development of BV. Chvapil utilized gas chromatography and demonstrated that&#xD;
      the longer period of time semen was present in the vagina, the more likely it resulted in a&#xD;
      strong and unattractive vaginal odor. Gallo showed that an incidental diagnosis of BV was&#xD;
      correlated with detection of sperm on gram stain, and frequent coitus with or without condom&#xD;
      use.&#xD;
&#xD;
      The investigator's goal in this study is to evaluate a novel postcoital consumer health&#xD;
      product and its effects on the complaints of continuous seepage of semen and vaginal odor&#xD;
      after intercourse.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 5, 2021</start_date>
  <completion_date type="Anticipated">September 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Subjects to be placed into one of two study groups, 1) immediate use and 2) 1 hour use</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Global Impression of Improvement (PGI-I)</measure>
    <time_frame>within 1 hour of use of product</time_frame>
    <description>Validated Questionnaire</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight of Investigational Device</measure>
    <time_frame>within 1 hour of use of product</time_frame>
    <description>Product weight (amount of fluid absorbed)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Vaginal Discharge</condition>
  <condition>Dyspareunia</condition>
  <condition>Female Sexual Dysfunction</condition>
  <condition>Vaginitis</condition>
  <condition>Bacterial Vaginoses</condition>
  <arm_group>
    <arm_group_label>Immediate Use</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this arm will be instructed to use the study device for 2 minutes and remove</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1 hour use</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this arm will be instructed to use the product for one hour and then remove</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tampon-like device for absorption of sexual fluids</intervention_name>
    <description>Subjects will insert a tampon-like device to absorb sexual fluids after intercourse</description>
    <arm_group_label>1 hour use</arm_group_label>
    <arm_group_label>Immediate Use</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Heterosexual&#xD;
&#xD;
          -  Age 25-50&#xD;
&#xD;
          -  Has used tampons in the past 5 years&#xD;
&#xD;
          -  Sexually active (vaginal intercourse, minimum once per week)&#xD;
&#xD;
          -  Answered &quot;moderate&quot; to &quot;severe&quot; to being bothered by dripping/discomfort on Patient&#xD;
             Global Impression of Severity (PGI-S) questionnaire &quot;on minutes, hours, or following&#xD;
             day&quot;&#xD;
&#xD;
          -  Willing and able to use product&#xD;
&#xD;
          -  Understands, reads, writes, and speaks English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Currently using condoms&#xD;
&#xD;
          -  Unable to use device due to poor motor function&#xD;
&#xD;
          -  Chronic disease which makes prone to infection (diabetes, autoimmune)&#xD;
&#xD;
          -  Recurrent yeast infections&#xD;
&#xD;
          -  Recurrent Urinary tract infection (UTI) (&gt;2 within the past year)&#xD;
&#xD;
          -  Diagnosis of pelvic organ prolapse (Stage II or greater)&#xD;
&#xD;
          -  Previous pelvic or vaginal surgery which, in the opinion of the investigator, may&#xD;
             prevent proper use of product&#xD;
&#xD;
          -  Unable to sign informed consent&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Cynthia Evaniecki</last_name>
    <phone>973-537-5557</phone>
    <email>cevaniecki@gsunj.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Center for Specialized Women's Health, division of Garden State Urology</name>
      <address>
        <city>Denville</city>
        <state>New Jersey</state>
        <zip>07834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Evaniecki</last_name>
      <phone>973-537-5557</phone>
      <email>cevaniecki@gsunj.com</email>
    </contact>
    <contact_backup>
      <phone_ext>Ingber</phone_ext>
      <email>mingber@gsunj.com</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Intber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 28, 2021</study_first_submitted>
  <study_first_submitted_qc>May 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2021</study_first_posted>
  <last_update_submitted>May 8, 2021</last_update_submitted>
  <last_update_submitted_qc>May 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Atlantic Health System</investigator_affiliation>
    <investigator_full_name>Michael Ingber</investigator_full_name>
    <investigator_title>Director of The Center for Specialized Women's Health, division of Garden State Urology/Atlantic Health System</investigator_title>
  </responsible_party>
  <keyword>vaginal discharge</keyword>
  <keyword>dripping</keyword>
  <keyword>vaginal odor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaginosis, Bacterial</mesh_term>
    <mesh_term>Vaginitis</mesh_term>
    <mesh_term>Dyspareunia</mesh_term>
    <mesh_term>Vaginal Discharge</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

